Published in Am J Pathol on December 01, 1989
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev (1995) 1.90
Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn (2008) 1.82
An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol (1992) 1.74
Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn (2001) 1.47
Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol (1999) 1.38
High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol (2000) 1.24
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg (2002) 1.16
Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci (1994) 1.06
The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am J Pathol (1991) 1.02
The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol (1995) 0.97
Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Am J Pathol (1991) 0.95
Clinicopathologic implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients. J Clin Pathol (1995) 0.84
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant (1992) 0.80
Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Am J Pathol (1992) 0.80
Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency. Am J Pathol (1993) 0.78
Two cases of post transplant lymphoproliferative disorder in lung transplant recipients. Korean J Intern Med (2004) 0.78
Systematic targeted integration to study Albumin gene control elements. PLoS One (2011) 0.75
Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc (1995) 0.75
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc (1997) 0.75
Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans. Am J Pathol (1994) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A (1982) 10.50
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell (1985) 10.13
Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes. Cell (1981) 9.09
Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science (1967) 8.62
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci U S A (1983) 7.01
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell (1988) 5.49
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell (1986) 5.13
Clustered arrangement of immunoglobulin lambda constant region genes in man. Nature (1981) 4.87
Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci U S A (1982) 4.70
Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. Science (1983) 4.04
Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci U S A (1984) 3.91
Evolution of human immunoglobulin kappa J region genes. J Biol Chem (1982) 3.41
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Early events in Epstein-Barr virus infection provide a model for B cell activation. J Exp Med (1985) 3.19
Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature (1986) 2.57
The approaching era of the tumor suppressor genes. Science (1987) 2.43
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res (1981) 2.39
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A (1986) 2.09
The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature (1986) 2.07
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
The isolation of high molecular weight DNA from whole organisms or large tissue masses. Anal Biochem (1978) 1.81
Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science (1987) 1.80
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res (1981) 1.72
Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Int Rev Exp Pathol (1985) 1.35
Variable methylation of the ribosomal RNA genes of the rat. Nucleic Acids Res (1982) 1.33
Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements. Nature (1984) 1.23
Complex translocation disrupts c-myc regulation in a human plasma cell myeloma. Mol Cell Biol (1988) 1.22
Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood (1988) 1.19
Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunological phenotype. Transplantation (1982) 1.10
Tumors arising in organ transplant recipients. Adv Cancer Res (1978) 1.04
B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus. J Virol (1988) 1.03
Defective immune surveillance in viral carcinogenesis. Lab Invest (1984) 0.98
The t(8;14) breakpoint of the EW 36 undifferentiated lymphoma cell line lies 5' of MYC in a region prone to involvement in endemic Burkitt's lymphomas. Nucleic Acids Res (1988) 0.89
Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc (1988) 0.86
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68
Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89
Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant (1992) 1.54
Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology (2000) 1.54
Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52
Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology (1996) 1.42
Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology (2000) 1.36
Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology (1999) 1.29
Development and experience with an integrated system for transplantation telepathology. Hum Pathol (2001) 1.23
Comparison of UW with other solutions for liver preservation in dogs. Clin Transplant (1989) 1.20
Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant (2009) 1.20
Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc (1993) 1.08
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc (1991) 1.06
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc (1994) 1.03
The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am J Pathol (1991) 1.02
Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc (1996) 0.99
Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation (1995) 0.98
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation (1999) 0.96
The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation (1992) 0.91
Antibody deposition in liver allografts with chronic rejection. Transplant Proc (1987) 0.90
Prevention of spontaneous diabetes in BB rats with FK 506. Lancet (1990) 0.90
Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology (2001) 0.90
Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Mod Pathol (1998) 0.86
Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue. Mol Diagn (2001) 0.86
Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. J Rheumatol (1989) 0.86
Posttransplantation cyclosporine-induced lymphoproliferative disorders: clinical and radiologic manifestations. Radiology (1987) 0.83
Detection of Y chromosome sequences in a 45,X/46,XXq--patient by Southern blot analysis of PCR-amplified DNA and fluorescent in situ hybridization (FISH). Am J Med Genet (1995) 0.83
Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing. Surgery (1990) 0.82
FK 506 prevents spontaneous diabetes in the BB rat. Transplant Proc (1991) 0.80
Mucosal glutaminase activity and histology as parameters of small bowel preservation injury. J Surg Res (1994) 0.80
Clinical significance of elevated alpha-fetoprotein in adults and children. Dig Dis Sci (2001) 0.80
Composite lymphoma (Hodgkin's and non-Hodgkin's) of the spleen in a previously untreated patient. Acta Haematol (1986) 0.79
Evaluation of preservation conditions and various solutions for small bowel preservation. Transplantation (1994) 0.79
Chronic Pneumocystis carinii infection of the liver. A case report and review of the literature. J Clin Gastroenterol (1992) 0.79
Mixed chimerism to induce tolerance for solid organ transplantation. J Pediatr Surg (1991) 0.79
Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc (1992) 0.78
The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion. Transplantation (1994) 0.78
Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. Transplant Proc (1991) 0.78
In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha. In Vitro Cell Dev Biol Anim (1998) 0.78
Effect of aminoguanidine and cyclosporine on lung allograft rejection. Ann Thorac Surg (1996) 0.77
The antigenicity of serum proteins and their role in xenograft rejection. Transplant Proc (1996) 0.75
Histopathology of renal posttransplant lymphoproliferation: comparison with rejection using the Banff schema. Am J Kidney Dis (1996) 0.75
Interleukin-10 production by a B-cell line derived from human post-transplant lymphoproliferative disease. Hematol Oncol (1995) 0.75
Giant lymph node hyperplasia: clinical and immunohistologic correlation of an intermediate variant. Ear Nose Throat J (1985) 0.75
Dynamics of bronchoalveolar lavage in the canine lung transplant. Transplant Proc (1988) 0.75
Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferative disease. Am J Surg Pathol (1996) 0.75
Allograft liver biopsy in patients with Epstein-Barr virus-associated posttransplant lymphoproliferative disease. Am J Surg Pathol (2001) 0.75
Effect of FK 506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. Transplant Proc (1991) 0.75
Inhibitory effect of FK 506 on autoimmune thyroid disease in the PVG rat. Ann N Y Acad Sci (1993) 0.75
Histocompatibility in cardiac transplantation with particular reference to immunopathology of positive serologic crossmatch. Clin Immunol Immunopathol (1983) 0.75